Surgery plays an important role in the treatment of breast cancer. The main goals of surgical treatment are complete removal of the primary tumor and determination of lymph node involvement. Mastectomy is recommended for large or multicentric tumors while breast-conserving surgery such as lumpectomy is preferred when possible. Sentinel lymph node biopsy is the standard method for staging axillary lymph nodes in clinically node-negative patients. Reconstruction options after mastectomy include implants, TRAM flaps, and latissimus dorsi flaps. Overall, mastectomy and breast-conserving surgery have been shown to have equivalent survival outcomes when combined with radiation or chemotherapy.
Management of Early Breast Cancer (by Dr. Akhil Kapoor)Akhil Kapoor
Comprehensive discussion on Management of Early Breast Cancer along with NCCN guidelines.
Slides prepared by Dr. Akhil Kapoor
(Resident, Department of Radiation Oncology,
Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner, Rajasthan, India
Oncoplastic Breast surgery is simultaneous application of lumpectomy and reconstructive techniques. The word ‘oncoplastic’ is derived from the Greek words ‘onco’ (tumour) and ‘plastic’ (to mould).
Approximately 10% to 30% of patients submitted to BCS alone are not satisfied with the aesthetic outcomes like “swan beak/ parrot beak deformities. The main reasons are related this is the tumour resection which can produce asymmetry, retraction, and volume changes in the breast.
Recently, increasing attention has been focused on oncoplastic procedures since the immediate application of plastic breast surgery techniques provide a wider local excision while still achieving the goals of a better breast shape and symmetry to obtain oncologically sound and aesthetically pleasing results. Thus, by means of customized techniques the surgeon ensures that oncologic principles are not jeopardized while meeting the needs of the patient from an aesthetic point of view.
http://cancer-treatment-madurai.com Breast cancer is a type of cancer that starts in the tissues of the breast. Dr.S.G.Balamurugan is one of the best cancer doctor in India, offers low cost breast cancer diagnosis, breast cancer treatments and breast cancer care at Guru Cancer Hospital, Madurai.
Management of Early Breast Cancer (by Dr. Akhil Kapoor)Akhil Kapoor
Comprehensive discussion on Management of Early Breast Cancer along with NCCN guidelines.
Slides prepared by Dr. Akhil Kapoor
(Resident, Department of Radiation Oncology,
Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner, Rajasthan, India
Oncoplastic Breast surgery is simultaneous application of lumpectomy and reconstructive techniques. The word ‘oncoplastic’ is derived from the Greek words ‘onco’ (tumour) and ‘plastic’ (to mould).
Approximately 10% to 30% of patients submitted to BCS alone are not satisfied with the aesthetic outcomes like “swan beak/ parrot beak deformities. The main reasons are related this is the tumour resection which can produce asymmetry, retraction, and volume changes in the breast.
Recently, increasing attention has been focused on oncoplastic procedures since the immediate application of plastic breast surgery techniques provide a wider local excision while still achieving the goals of a better breast shape and symmetry to obtain oncologically sound and aesthetically pleasing results. Thus, by means of customized techniques the surgeon ensures that oncologic principles are not jeopardized while meeting the needs of the patient from an aesthetic point of view.
http://cancer-treatment-madurai.com Breast cancer is a type of cancer that starts in the tissues of the breast. Dr.S.G.Balamurugan is one of the best cancer doctor in India, offers low cost breast cancer diagnosis, breast cancer treatments and breast cancer care at Guru Cancer Hospital, Madurai.
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018Summit Health
Summit Medical Group MD Anderson Cancer Center Lecture Series. A lecture and panel discussion format about the latest advances in surgery and innovative therapies for breast cancer presented by Summit Medical Group MD Anderson Cancer Center Specialists Dr. Lisa Mills, Dr. David Schreiber and Dr. Winnie Polen.
Breast Cancer Treatment: Where we are, Where we're going - April 24th, 2018Summit Health
Summit Medical Group MD Anderson Cancer Center Lecture Series. A lecture and panel discussion format about the latest advances in surgery and innovative therapies for breast cancer presented by Summit Medical Group MD Anderson Cancer Center Specialists Dr. Lisa Mills, Dr. David Schreiber and Dr. Winnie Polen.
this slide contain detail about chest wall tumor, its classification, presentation and management. This also contain chest wall reconstruction and way of reconstruction.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
1. ROLE OF SURGERY IN
CARCINOMA
BREAST
By-
DR NISHI KUMARI
MS GENERAL SURGERY
NALANDA MEDICAL COLLEGE
2. INTRODUCTION
BREAST CANCER IS SECOND LEADING
CAUSE OF CANCER RELATED DEATHS IN
THE WORLD
AS FAR AS ROLE OF SURGERY IS
CONCERNED OUR AIM IS ….
TO CLEAR THE PATIENT OF THE
LOCO REGIONAL DISEASE
3. TREATMENT FOR BREAST
CANCER IS GUIDED BY
Pathology of
the tumor
Staging of
tumor
And more
recent
insights into
breast
cancer
biology
4. EMPHASIS IS LAID ON :-
DEFINING DISEASE BIOLOGY AND
STATUS IN INDIVIDUAL PATIENTS, WITH
SUBSEQUENT TAILORING OF THERAPIES.
5. Surgery for carcinoma breast has travelled
from a halstedian era to era of breast
conservative surgery….
but the aim still remains the same…
and that is LOCOREGIONAL CONTROL of
the disease .
6. Surgical principles FOR
MANAGEMENT OF CA BREAST
Complete eradication of the primary tumor
Determination of involvement of regional
nodes and metastasis ifany
Wide excision with radiation therapy for local
tumors
Mastectomy being recommended for a
multicentric/largertumors.
8. Imporatant definitions
• Removal of entire breast tissue,nipple areola
complex,p.major and p.minor muscles and axillary
lymph nodes
Radical
mastectomy(halsted)
• Removal of entire breast tissue,nipple areola
complex
• And axillary lymph node level 1 and 2
Modified radical
mastectomy
• Removal of the totality of the glandular
• breast tissue with overlying skin ellipse
• and nipple-areola complex (no axillary
• surgery)
Simple mastectomy
9. • Removal of the totality of the glandular
breast tissue ,removal of nipple areola
complex with preservation of skin
envelope overlying the breasrt(followed
by immediate reconstruction)
Skin-sparing
mastectomy
(SSM)
• Removal of entire breast tissue with
preservation of nipple areola complex
and skin envelope
Nipple-sparing
mastectomy (NSM)
or total skin-sparing
mastectomy
(TSSM)
10. Radical mastectomy of halsted
William stewart halsted was the first to
perform and clearly document radical
mastectomy in US at john hopkins hospital
in 1882
Until mid 1970’s halsted mastectomy was
the standard of care for surgical treatment
of breast cancer
12. Currently ,early diagnosting imaging and
education with chemo,hormone and
radiotherapy have existentially eliminated the
need for classical halsted radical mastectomy
13. MODIFIED RADICAL
MASTECTOMY
NSABP B-04 trials in 1971 proved that there
was no survival advantage conferred by
radical mastectomy when compared to MRM
either for clinically node negative or node
positive breast cancer
Most acceptable and most widely practised
surgery
In present era
14. Modified radical mastectomy
Advantages over radical mastectomy:
Good postoperative cosmetic
appearance
Maintain motor activity in the arm
Low rate of postoperative arm oedema
Easy postoperative breast
reconstruction
15. TYPES OF MRM
• P.Major muscle is preserved
• P.Minor muscle along with level 1,2 and 3 of axillary
nodes removed
PATEYS MRM
• P.Minor muscle is divided and not removed
• All three level of lymphnodes are removed
SCANLONS
MRM
• P.Minor is retracted and not divided
• Only level 1 and 2 lymph nodes are removed
• Auchincloss’ Modified Radical Mastectomy is widely
practicednowadays
AUCHINCLOSS’
MRM
16. Three important structures should be
preserved durin MRM :
1.Axillary vein
2.Bell’s nerve(long thoracic nerve)
3.Cephalic vein
17. MRM
Limits of the modified radical mastectomy are delineated
laterally by the anterior margin of the latissimusdorsi muscle,
medially by the sternal border,
superiorly by thesubclavius muscle, and
inferiorly by the caudal extension of thebreast approximately 3 to 4 cm inferior to the
inframammary fold.
Skin flaps for the modified radical technique are planned with relation to the quadrant in
which the primary neoplasm is located.
Adequate margins are ensured by developing skin edges 3 to 5cm from the tumor
margin. Skin incisions are made perpendicular to the subcutaneous plane. Flap
thickness should vary with patient body habitus but ideally should be 7 to 8 mm thick.
Flap tension should be perpendicular to the chest wall with flap elevation deep to the
cutaneous vasculature, which is accentuated by flap retraction.
39. BREAST CONSERVATIVE
THERAPY
SHOULD BE PERFORMED :
IF TECHNICALLY POSSIBLE
PATIENTS PREFERENCE
AND NO C/I….TWO ABSOLUTE
CONTRAINDICATIONS FOR BCS BEING-
FAILURE TO ACHIEVE NEGATIVE MARGINS
WITHOUT CAUSING BREAST DEFORMITY
AND
INFLAMMATORY CARCINOMA BREAST
40. BCS
MOST IMPORTANT RISK FACTORS FOR
LOCAL RECURRENCE AFTER BCS-
POSITIVE MARGINS AND
YOUNG PATIENT AGE
41. THESE DAYS BCS IS ASSOCIATED WITH
DECREASED RISK OF RECURRENCE COZ OF
IMPROVED PATIENT SELECTION
BETTER QUALITY SURGERY
BETTER HISTOPATH EVALUATION OF
RESECTED MARGIN
USE OF TUMOR BED RADIOTHERAPY
BOOST
EXTENSIVE USE OF SYSTEMIC
ADJUVANT TREATMENT AND MORE
EFFECTIVE CHEMO REGIME
42. CHECKLIST FOR PLANNING
BCS
The extent and the location of the primary tumour
The size of the breast
The density of the breast parenchyma and the grade of ptosis of
the breast
The BMI and the body confrontation of the patient (very skinny,
slim, normal, obese, very obese)
Previous breast surgeries
Tumour biology – especially when considering neoadjuvant
treatment
Contraindications to radiotherapy
The age and comorbidities of the patient
Family history of the patient
Patient preference
43. BCS
1.Wide Local Excision (WLE)/ PartialMastectomy
Removal of unicentric tumour with 1cm
clearance margin.
Incision: Over tumour + Axillary
Dissection + RT
2.Quadrantectomy:
Removal of entire quadrant with ductal
system with 2-3cm normal breast tissue clearance.
Part ofQUART Therapy (Quadrantectomy +
Axillarydissection + RT) Notadvocated now.
3.Skin Sparing Mastectomy
4.Lumpectomy (=WLE)
Term rarely used
SR_Ca_Breast_
44. AXILLARY SURGERY
Presence of metastatic disease within axillary
lymph nodes is still the best single marker for
prognosis.
In early breast carcinoma, if there is no
clinically apparent nodes and the disease is
not multicentric, then sentinel nodebiopsy is
considered.
Otherwise Complete Axillary Dissection is
done
45. SLNB
STANDARD METHOD FOR STAGING OF
AXILLA IN CLINICALLY NODE NEGATIVE
PATIENTS OF BREAST CANCER
IF SLN FRE FROM CANCER, NO AXILLARY
LYMPH NODE DISSECTION NEEDED
46. PROCEDURE FOR SENTINEL
LYMPHNODE BIOPSY
SLN can be detected either by radioactive Tc-99m
labelled sulphur colloid or Isosulfan blue dye.However
combination of both gives better results.
Radioactive colloid is injected in subareolar region or
near the primary tumour; 2-24 hours before the
surgery.
Isosulfan blue dye is injected at the time of surgery in
the same region.
A hand held gamma camera is used to identify the
location of SLN.
47. 3-4cm transverse incision is given just below the hairline of
axilla.
Blunt dissection is done to visualise the dye containing
lymphatics which are traced to locate the SLN.
The SLN is removed and send for histopathological
examination
48. BREAST RECONSTRUCTION
Women undergoing mastectomy can be
offered immediate or delayed reconstruction of
breast
Patient counselling and patient selection are
very important steps in planning breast
reconstruction
49. METHODS OF
RECONSTRUCTION
Easiest type of reconstruction – a silicone gel
implant under the pectoralis major muscle
If skin at mastectomy site is poor (following
radiotherapy) or larger volume of tissue is
required
:- a musculocutaneous flap can be
constructed
50. Types of musculocutaneous flap-
LD FLAP
TRAM FLAP (gives excellent
cosmetic result)
DIEP FLAP (variation of tram
flap requiring less muscle harvesting…based
on deep inferior epigastric vessels) is
increasingly being used
51.
52. Woman with lines of trans–rectus abdominis muscle (TRAM)reconstruction
incisions.
A lines of reconstructed breast incisions
C line of abdominal surgery incision
53. A mastectomy site
B right trans rectus abdominis muscle
C left trans rectus abdominal muscle
D segment of abdominal tissues: skin and fat, to be transferred along
with muscle to create the new breast
54. A lines of reconstructed breast incisions
B right trans rectus abdominis muscle
C left TRAM muscle is swung over to re–create the new breast
D incision circle
E line of abdominal surgery
56. Woman with Lattisimus Dorsi muscle swung
forward to
re–create the new breast.
A Lattisimus Dorsi muscle in new location to re–
create
breast
57. conclusion
According to Two large trials (NSABP) and
MILAN 1 trial
MASTECTOMY AND BREAST
CONSERVING THERAPY HAVE BEEN
SHOWN TO BE EQUIVALENT IN TERMS OF
PATIENT SURVIVAL , AND THE CHOICE OF
SURGICAL TREATMENT IS INDIVIDUALIZED
.
58. In the era of minimal access surgery, role of
surgery is still pivotal in management of
carcinoma breast
&
A complete locoregional control of the disease
should be aimed for in management of
carcinoma breast